H-1B sponsors › S › Sarepta Therapeutics, Inc.
Does Sarepta Therapeutics, Inc. sponsor H-1B visas?
U.S. Department of Labor filings, Oct 2025 – Jun 2026.
Roles and salaries on Sarepta Therapeutics, Inc.'s H-1B filings
| Job title | Filings | Median wage | Middle 50% |
|---|---|---|---|
| Quality Control Investigations Manager | 1 | $126,000 | — |
| Director, Regulatory Affairs CMC | 1 | $197,000 | — |
| Sr. Principal Engineer, Manufacturing Sciences & Technology | 1 | $170,000 | — |
| Senior Scientist, Discovery Chemistry | 1 | $131,000 | — |
| Director, Quality Control | 1 | $191,000 | — |
| QC Analyst | 1 | $91,978 | — |
Where Sarepta Therapeutics, Inc.'s H-1B roles are based
- Andover, MA — 3
- Bedford, MA — 2
- Cambridge, MA — 1
Other H-1B sponsors in Andover, MA
All 31 sponsors in Andover, MA →
Questions
Does Sarepta Therapeutics, Inc. sponsor H-1B visas?
Yes. Sarepta Therapeutics, Inc. has filed H-1B paperwork: 6 certified H-1B labor condition applications (LCAs) in Department of Labor data for Oct 2025 – Jun 2026. An LCA is filed before an H-1B petition, so it is a strong sign of sponsorship but not a guarantee.
How much does Sarepta Therapeutics, Inc. pay H-1B workers?
Median wages stated on Sarepta Therapeutics, Inc.'s certified LCAs range from $91,978 to $197,000 a year across its most common roles; Quality Control Investigations Manager had a median of $126,000.
Which roles does Sarepta Therapeutics, Inc. sponsor?
The most frequent job titles on Sarepta Therapeutics, Inc.'s LCAs are Quality Control Investigations Manager, Director, Regulatory Affairs CMC, Sr. Principal Engineer, Manufacturing Sciences & Technology.
Source: U.S. Department of Labor, Office of Foreign Labor Certification — LCA disclosure data, Oct 2025 – Jun 2026. An LCA (Labor Condition Application) is the step an employer files before an H-1B petition; a certified LCA is not a visa approval, and past filings don't guarantee an employer will sponsor you. Salaries are the wages employers stated on the LCAs. Offerbound is not affiliated with the companies listed.